- Home
- FLUX vs GDTC Comparison
FLUX vs GDTC Comparison
Compare FLUX & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- GDTC
- Stock Information
- Founded
- FLUX N/A
- GDTC 2018
- Country
- FLUX United States
- GDTC Singapore
- Employees
- FLUX N/A
- GDTC N/A
- Industry
- FLUX Industrial Machinery/Components
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- GDTC Health Care
- Exchange
- FLUX Nasdaq
- GDTC Nasdaq
- Market Cap
- FLUX 25.4M
- GDTC 28.0M
- IPO Year
- FLUX N/A
- GDTC 2023
- Fundamental
- Price
- FLUX $1.90
- GDTC $2.11
- Analyst Decision
- FLUX Strong Buy
- GDTC Buy
- Analyst Count
- FLUX 2
- GDTC 1
- Target Price
- FLUX $6.00
- GDTC $5.00
- AVG Volume (30 Days)
- FLUX 135.9K
- GDTC 6.7K
- Earning Date
- FLUX 08-15-2025
- GDTC 01-01-0001
- Dividend Yield
- FLUX N/A
- GDTC N/A
- EPS Growth
- FLUX N/A
- GDTC N/A
- EPS
- FLUX N/A
- GDTC N/A
- Revenue
- FLUX $63,074,000.00
- GDTC $368,838.00
- Revenue This Year
- FLUX $11.10
- GDTC $5.37
- Revenue Next Year
- FLUX $12.66
- GDTC N/A
- P/E Ratio
- FLUX N/A
- GDTC N/A
- Revenue Growth
- FLUX N/A
- GDTC N/A
- 52 Week Low
- FLUX $1.15
- GDTC $1.20
- 52 Week High
- FLUX $4.75
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- FLUX 54.96
- GDTC 39.85
- Support Level
- FLUX $1.72
- GDTC $2.09
- Resistance Level
- FLUX $2.53
- GDTC $2.22
- Average True Range (ATR)
- FLUX 0.20
- GDTC 0.09
- MACD
- FLUX 0.01
- GDTC -0.01
- Stochastic Oscillator
- FLUX 41.12
- GDTC 0.00
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.